Transcription

1 Antibiotic resistance Fact sheet Updated November 2017 Key facts Antibiotic resistance is one of the biggest threats to global health, food security, and development today. Antibiotic resistance can affect anyone, of any age, in any country. Antibiotic resistance occurs naturally, but misuse of antibiotics in humans and animals is accelerating the process. A growing number of infections such as pneumonia, tuberculosis, gonorrhoea, and salmonellosis are becoming harder to treat as the antibiotics used to treat them become less effective. Antibiotic resistance leads to longer hospital stays, higher medical costs and increased mortality. Introduction Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs when bacteria change in response to the use of these medicines. Bacteria, not humans or animals, become antibiotic-resistant. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antibiotic resistance leads to higher medical costs, prolonged hospital stays, and increased mortality. The world urgently needs to change the way it prescribes and uses antibiotics. Even if new medicines are developed, without behaviour change, antibiotic resistance will remain a major threat. Behaviour changes must also include actions to reduce the spread of infections through vaccination, hand washing, practising safer sex, and good food hygiene. Scope of the problem Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases are becoming harder, and sometimes impossible, to treat as antibiotics become less effective.

2 Where antibiotics can be bought for human or animal use without a prescription, the emergence and spread of resistance is made worse. Similarly, in countries without standard treatment guidelines, antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public. Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill. Prevention and control Antibiotic resistance is accelerated by the misuse and overuse of antibiotics, as well as poor infection prevention and control. Steps can be taken at all levels of society to reduce the impact and limit the spread of resistance. Individuals To prevent and control the spread of antibiotic resistance, individuals can: Only use antibiotics when prescribed by a certified health professional. Never demand antibiotics if your health worker says you don t need them. Always follow your health worker s advice when using antibiotics. Never share or use leftover antibiotics. Prevent infections by regularly washing hands, preparing food hygienically, avoiding close contact with sick people, practising safer sex, and keeping vaccinations up to date. Prepare food hygienically, following the WHO Five Keys to Safer Food (keep clean, separate raw and cooked, cook thoroughly, keep food at safe temperatures, use safe water and raw materials) and choose foods that have been produced without the use of antibiotics for growth promotion or disease prevention in healthy animals. Policy makers To prevent and control the spread of antibiotic resistance, policy makers can: Ensure a robust national action plan to tackle antibiotic resistance is in place. Improve surveillance of antibiotic-resistant infections. Strengthen policies, programmes, and implementation of infection prevention and control measures. Regulate and promote the appropriate use and disposal of quality medicines. Make information available on the impact of antibiotic resistance.

3 Health professionals To prevent and control the spread of antibiotic resistance, health professionals can: Prevent infections by ensuring your hands, instruments, and environment are clean. Only prescribe and dispense antibiotics when they are needed, according to current guidelines. Report antibiotic-resistant infections to surveillance teams. Talk to your patients about how to take antibiotics correctly, antibiotic resistance and the dangers of misuse. Talk to your patients about preventing infections (for example, vaccination, hand washing, safer sex, and covering nose and mouth when sneezing). Healthcare industry To prevent and control the spread of antibiotic resistance, the health industry can: Invest in research and development of new antibiotics, vaccines, diagnostics and other tools. Agriculture sector To prevent and control the spread of antibiotic resistance, the agriculture sector can: Only give antibiotics to animals under veterinary supervision. Not use antibiotics for growth promotion or to prevent diseases in healthy animals. Vaccinate animals to reduce the need for antibiotics and use alternatives to antibiotics when available. Promote and apply good practices at all steps of production and processing of foods from animal and plant sources. Improve biosecurity on farms and prevent infections through improved hygiene and animal welfare. Recent developments While there are some new antibiotics in development, none of them are expected to be effective against the most dangerous forms of antibiotic-resistant bacteria. Given the ease and frequency with which people now travel, antibiotic resistance is a global problem, requiring efforts from all nations and many sectors. Impact

4 When infections can no longer be treated by first-line antibiotics, more expensive medicines must be used. A longer duration of illness and treatment, often in hospitals, increases health care costs as well as the economic burden on families and societies. Antibiotic resistance is putting the achievements of modern medicine at risk. Organ transplantations, chemotherapy and surgeries such as caesarean sections become much more dangerous without effective antibiotics for the prevention and treatment of infections. WHO response Tackling antibiotic resistance is a high priority for WHO. A global action plan on antimicrobial resistance, including antibiotic resistance, was endorsed at the World Health Assembly in May The global action plan aims to ensure prevention and treatment of infectious diseases with safe and effective medicines. The Global action plan on antimicrobial resistance has 5 strategic objectives: To improve awareness and understanding of antimicrobial resistance. To strengthen surveillance and research. To reduce the incidence of infection. To optimize the use of antimicrobial medicines. To ensure sustainable investment in countering antimicrobial resistance. A political declaration endorsed by Heads of State at the United Nations General Assembly in New York in September 2016 signaled the world s commitment to taking a broad, coordinated approach to address the root causes of antimicrobial resistance across multiple sectors, especially human health, animal health and agriculture. WHO is supporting Member States to develop national action plans on antimicrobial resistance, based on the global action plan. WHO has been leading multiple initiatives to address antimicrobial resistance: World Antibiotic Awareness Week Held every November since 2015 with the theme Antibiotics: Handle with care, the global, multi-year campaign has increasing volume of activities during the week of the campaign. The Global Antimicrobial Resistance Surveillance System (GLASS) The WHO-supported system supports a standardized approach to the collection, analysis and sharing of data related to antimicrobial resistance at a global level to inform decision-making, drive local, national and regional action. Global Antibiotic Research and Development Partnership (GARDP)

5 A joint initiative of WHO and Drugs for Neglected Diseases initiative (DNDi), GARDP encourages research and development through public-private partnerships. By 2023, the partnership aims to develop and deliver up to four new treatments, through improvement of existing antibiotics and acceleration of the entry of new antibiotic drugs. Interagency Coordination Group on Antimicrobial Resistance (IACG) The United Nations Secretary-General has established IACG to improve coordination between international organizations and to ensure effective global action against this threat to health security. The IACG is co-chaired by the UN Deputy Secretary-General and the Director General of WHO and comprises high level representatives of relevant UN agencies, other international organizations, and individual experts across different sectors.

Antimicrobial Resistance, yes we care! The European Joint Action Context of the Joint Action General objectives Inclusive governance Conclusion Context of the Joint Action 1. Context of this Joint Action

National Action Plan development support tools Sample Checklist This checklist was developed to be used by multidisciplinary teams in countries to assist with the development of their national action plan

GHSA Meeting on Step towards Regional Strategic Collaboration in Asia-Pacific on Workforce Development, National Laboratory System Strengthening and Antimicrobial Resistance Prevention to Respond to Global

Control and monitoring of the use of antibiotics as a strategy against antimicrobials resistance Christiane Santiago Maia ANVISA - Brazilian Health Regulatory Agency s Context The burden of deaths from

Antimicrobial Stewardship: The South African Perspective Precious Matsoso Director General; National Department of Health; South Africa 13 th November 2015 Why do we need an AMR strategy and implementation

Global Framework for Development & Stewardship to Combat Antimicrobial Resistance Draft Roadmap CONTENTS ABBREVIATIONS... 3 CONTEXT... 4 OBJECTIVES... 4 WHAT DO WE UNDERSTAND BY FRAMEWORK?... 4 HOW DOES

of Conferences of OIE Regional Commissions organised since 1 June 2013 endorsed by the Assembly of the OIE on 29 May 2014 2 12 th Conference of the OIE Regional Commission for the Middle East Amman (Jordan),

2 nd Joint Conference on the Antimicrobial Resistance Action Plan (AMRAP) and the Strategy for the Control of Antimicrobial Resistance in Ireland (SARI) 1. Background Antibiotic stewardship Implementing

What Canadian vets need to know and explain about antimicrobial resistance By John F. Prescott, MA, VetMB, PhD Major changes are underway regarding how agricultural use of antibiotics is regulated in food

To protect animal welfare and public health and safety The Dog Meat Trade in Indonesia: A Cruel and Dangerous Trade Every year, millions of dogs are captured and stolen to be transported throughout Indonesia

7 December 2017 Committee for Medicinal Products for Veterinary Use (CVMP) Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018 Chairpersons Chair: D. Murphy Status Adopted in December

Strategic and Technical Advisory Group on Antimicrobial Resistance (STAG-AMR) Report of Second Meeting 14-16 April 2014 WHO Headquarters, Geneva PANDEMIC AND EPIDEMIC DISEASES WHO/HSE/PED/AIP/2014.4 Strategic

Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite

The Third OIE Global Conference on Veterinary Education and the Role of the Veterinary Statutory Body was held in Foz do Iguaçu (Brazil) from 4 to 6 December 2013. The Conference addressed the need for

OIE Collaborating Centre for Animal Welfare Science and Bioethical Analysis An innovative, multi-centre partnership between the New Zealand and Australian Governments and internationally recognised research

Mariano Ramos Chargé de Mission OIE Programmes Department Introductory presentation Regional Table Top Exercise for Countries of Middle East and North Africa Tunisia; 11 13 July 2017 Welcome to the Regional

12.08.2009 Information note regarding the Danish and EU restrictions of non-therapeutical use of antibiotics for growth promotion Denmark is a major animal food producer in Europe, and the worlds largest

Antibiotic Resistance & chicken Chicken Farmers of Canada (CFC) supports the judicious use of antibiotics that have been approved by the Veterinary Drugs Directorate of Health Canada, in order to ensure

Health and Safety Top Tips for Volunteers Keeping yourself safe whilst out and about When you are out and about volunteering for Guide Dogs it is important that you consider your safety at all times. To

Milano, August 31 2015 International Conference Prevention and control of Campylobacter in the poultry production system Dr. Silvio Borrello Direzione generale della sanità animale e dei farmaci veterinari

EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment Summary Globally, pharmaceutical products are regularly administered to both livestock

FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14

Antibiotic Resistance ACVM information paper Background Within New Zealand and internationally, concerns have been raised about an association between antibiotics used routinely to protect the health of

ruma RESPONSIBLE USE OF MEDICINES IN AGRICULTURE ALLIANCE GUIDELINES Cattle Responsible use of antimicrobials in Cattle production RUMA guidelines for the responsible use of antimicrobials by cattle farmers

Veterinary Statutory Bodies: Their roles and importance in the good governance of Veterinary Services Regional Seminar on Veterinary Statutory Bodies in the Eastern European countries context 12-13 December

Options for a global development and stewardship framework to combat AMR Consultation of Member States and relevant partners Geneva, 29 February 2016 Peter Beyer Resolution WHA68.7 Requests the to develop

Veterinary Public Health (VPH) Veterinary Public Health is the application of professional veterinary knowledge, skills and resources to the protection and improvement of human health. VPH plays a fundamental

European Regional Verification Commission for Measles and Rubella Elimination (RVC) TERMS OF REFERENCE 6 December 2011 Address requests about publications of the WHO Regional Office for Europe to: Publications

Impact of NHS England Quality Indicators on Antimicrobial Resistance Professor Alan Johnson National Infection Service Public Health England A Risk Assessment of Antibiotic Pan-Drug Resistance in the UK:

ACCELERATING DIAGNOSTICS USE TO PREVENT AMR ABOUT FIND FIND was founded in 2003 to bridge existing development gaps for essential diagnostics by initiating and coordinating research and development (R&D)

SEA-HLM-407 Distribution: General Regional Strategy on Prevention and Containment of Antimicrobial Resistance 2010-2015 World Health Organization 2010 All rights reserved. Requests for publications, or

(AMR) is an increasingly serious threat to global public health. The problem is so serious that it threatens the achievements of modern medicine. A post-antibiotic era in which common infections and minor

Multi-Drug Resistant Organisms (MDRO) 2016 What are MDROs? Multi-drug resistant organisms, or MDROs, are bacteria resistant to current antibiotic therapy and therefore difficult to treat. MDROs can cause

Terms and Conditions (from February 2016) General to all Four Paws Services 1. By attending doggie daycare, kennels or using any of Four Paws Pet Services you agree to all terms and conditions detailed

Antimicrobial Stewardship in Food Animals in Canada April, 2016 This document was prepared by the National Farmed Animal Health and Welfare Council. The Council was formed in 2010 to advise governments

Summary of the latest data on antibiotic resistance in the European Union EARS-Net surveillance data November 2017 For most bacteria reported to the European Antimicrobial Resistance Surveillance Network

Global Conference on Rabies Control: Towards Sustainable Prevention at the Source Seoul (Republic of Korea), 7-9 September 2011 T he World Organisation for Animal Health (OIE) is committed to supporting